FR2669338A1 - Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline. - Google Patents

Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline. Download PDF

Info

Publication number
FR2669338A1
FR2669338A1 FR9014519A FR9014519A FR2669338A1 FR 2669338 A1 FR2669338 A1 FR 2669338A1 FR 9014519 A FR9014519 A FR 9014519A FR 9014519 A FR9014519 A FR 9014519A FR 2669338 A1 FR2669338 A1 FR 2669338A1
Authority
FR
France
Prior art keywords
sep
peptide
antibodies
vif
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR9014519A
Other languages
English (en)
French (fr)
Other versions
FR2669338B1 (Direct
Inventor
Avrameas Alexandre
Guillet Jean Gerard
Moraillon Anne
Strosberg Arthur Donny
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR9014519A priority Critical patent/FR2669338A1/fr
Priority to PCT/FR1991/000917 priority patent/WO1992009632A1/fr
Priority to DE69130457T priority patent/DE69130457T2/de
Priority to EP92900187A priority patent/EP0564477B1/fr
Priority to AT92900187T priority patent/ATE172983T1/de
Publication of FR2669338A1 publication Critical patent/FR2669338A1/fr
Application granted granted Critical
Publication of FR2669338B1 publication Critical patent/FR2669338B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K16/114—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR9014519A 1990-11-21 1990-11-21 Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline. Granted FR2669338A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR9014519A FR2669338A1 (fr) 1990-11-21 1990-11-21 Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.
PCT/FR1991/000917 WO1992009632A1 (fr) 1990-11-21 1991-11-20 Fragments de la proteine env du virus de l'immunodeficience feline, anticorps et leurs applications dans le diagnostic
DE69130457T DE69130457T2 (de) 1990-11-21 1991-11-20 Peptidfragmente des env-proteins vom immunschwäche-virus der katze und ihre verwendung in der diagnostik
EP92900187A EP0564477B1 (fr) 1990-11-21 1991-11-20 Fragments de la proteine env du virus de l'immunodeficience feline, anticorps et leurs applications dans le diagnostic
AT92900187T ATE172983T1 (de) 1990-11-21 1991-11-20 Peptidfragmente des env-proteins vom immunschwäche-virus der katze und ihre verwendung in der diagnostik

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9014519A FR2669338A1 (fr) 1990-11-21 1990-11-21 Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.

Publications (2)

Publication Number Publication Date
FR2669338A1 true FR2669338A1 (fr) 1992-05-22
FR2669338B1 FR2669338B1 (Direct) 1995-03-03

Family

ID=9402430

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9014519A Granted FR2669338A1 (fr) 1990-11-21 1990-11-21 Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.

Country Status (5)

Country Link
EP (1) EP0564477B1 (Direct)
AT (1) ATE172983T1 (Direct)
DE (1) DE69130457T2 (Direct)
FR (1) FR2669338A1 (Direct)
WO (1) WO1992009632A1 (Direct)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692279A1 (fr) * 1992-06-16 1993-12-17 Centre Nat Rech Scient Séquences nucléotidiques issues de la souche WO du vif et leurs fragments, applications desdites séquences à l'expression de peptides immunogènes et au diagnostic de l'immunodéficience féline.
FR2692270A1 (fr) * 1992-06-16 1993-12-17 Centre Nat Rech Scient Peptides immunogènes et/ou neutralisants de vif de souche WO et leurs applications au diagnostic et à la prévention de l'immunodéficience féline.
FR2692269A1 (fr) * 1992-06-16 1993-12-17 Centre Nat Rech Scient Peptides immunogènes et/ou neutralisants de vif de souche WO et leurs applications au diagnostic et à la prévention de l'immunodéficience féline.
EP0577458A1 (fr) * 1992-06-16 1994-01-05 Centre National De La Recherche Scientifique Séquences nucléotidiques et peptidiques issues de la souche Wo du VIF et applications desdites séquences au diagnostic et à la prévention de l'immunodéficience féline
FR2769916A1 (fr) * 1997-10-17 1999-04-23 Centre Nat Rech Scient Peptides issus du gene env du virus de l'immunodeficience feline et leurs applications immunoprotectrices et vaccinales

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591572A (en) * 1991-06-14 1997-01-07 St. Vincents Institute Of Medical Research Limited Detection of mammalian immunodeficiency viruses
GB9215232D0 (en) * 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
GB9215233D0 (en) * 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
GB9219936D0 (en) * 1992-09-21 1992-11-04 Pitman Moore Inc Vaccines
EP0670901A1 (en) * 1993-03-11 1995-09-13 Akzo Nobel N.V. Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus
US6300118B1 (en) 1995-06-07 2001-10-09 American Home Products Corporation Plasmids comprising a genetically altered feline immunodeficiency virus genome
US5849303A (en) * 1995-06-07 1998-12-15 American Home Products Corporation Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
WO2005026733A1 (en) 2003-09-11 2005-03-24 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
AU2005267607B8 (en) 2003-09-11 2009-07-16 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
EP1709447B1 (en) * 2003-12-18 2009-06-24 Idexx Laboratories, Inc. Method for detecting feline immunodeficiency virus
AU2005215629B2 (en) * 2004-02-19 2009-01-29 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
EP1761556A1 (en) 2004-06-30 2007-03-14 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus (fiv) comprising the use of peptides derived from the v3 region of the fiv env protein
US7291338B2 (en) 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
EP2553452B1 (en) 2010-04-02 2015-03-04 IDEXX Laboratories, Inc. Detection of feline immunodeficiency virus

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006510A1 (en) * 1988-12-05 1990-06-14 Idexx Corporation Monoclonal antibodies to feline-t-lymphotropic lentivirus
WO1990013573A1 (en) * 1989-05-08 1990-11-15 Idexx Corporation Polypeptides of feline t-cell lymphotropic lentivirus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006510A1 (en) * 1988-12-05 1990-06-14 Idexx Corporation Monoclonal antibodies to feline-t-lymphotropic lentivirus
WO1990013573A1 (en) * 1989-05-08 1990-11-15 Idexx Corporation Polypeptides of feline t-cell lymphotropic lentivirus

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PROC. NATL. ACAD. SCI. USA, vol. 86, août 1989, pages 5743-5747; R.L. TALBOTT et al.: "Nucleotide sequence and genomic organization of feline immunodeficiency virus" *
PROC. NATL. ACAD. SCI. USA, vol. 86, octobre 1989, pages 8088-8092; R.A. OLMSTED et al.: "Nucleotide sequence analysis of feline immunodeficiency virus: Genome organization and relationship to other lentiviruses" *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692279A1 (fr) * 1992-06-16 1993-12-17 Centre Nat Rech Scient Séquences nucléotidiques issues de la souche WO du vif et leurs fragments, applications desdites séquences à l'expression de peptides immunogènes et au diagnostic de l'immunodéficience féline.
FR2692270A1 (fr) * 1992-06-16 1993-12-17 Centre Nat Rech Scient Peptides immunogènes et/ou neutralisants de vif de souche WO et leurs applications au diagnostic et à la prévention de l'immunodéficience féline.
FR2692269A1 (fr) * 1992-06-16 1993-12-17 Centre Nat Rech Scient Peptides immunogènes et/ou neutralisants de vif de souche WO et leurs applications au diagnostic et à la prévention de l'immunodéficience féline.
EP0577458A1 (fr) * 1992-06-16 1994-01-05 Centre National De La Recherche Scientifique Séquences nucléotidiques et peptidiques issues de la souche Wo du VIF et applications desdites séquences au diagnostic et à la prévention de l'immunodéficience féline
FR2769916A1 (fr) * 1997-10-17 1999-04-23 Centre Nat Rech Scient Peptides issus du gene env du virus de l'immunodeficience feline et leurs applications immunoprotectrices et vaccinales
WO1999020650A1 (fr) * 1997-10-17 1999-04-29 Centre National De La Recherche Scientifique (Cnrs) Peptides issus de gene env du virus de l'immunodeficience feline et leurs applications
US6391304B1 (en) 1997-10-17 2002-05-21 Centre National De La Recherche Scientifique Peptides derived from the ENV gene of the feline immunodeficiency virus and their applications

Also Published As

Publication number Publication date
WO1992009632A1 (fr) 1992-06-11
EP0564477B1 (fr) 1998-11-04
EP0564477A1 (fr) 1993-10-13
FR2669338B1 (Direct) 1995-03-03
DE69130457T2 (de) 1999-05-27
ATE172983T1 (de) 1998-11-15
DE69130457D1 (de) 1998-12-10

Similar Documents

Publication Publication Date Title
EP0564477B1 (fr) Fragments de la proteine env du virus de l'immunodeficience feline, anticorps et leurs applications dans le diagnostic
US5304466A (en) HIV-3 retrovirus and its use
EP0239425B1 (fr) Rétrovirus du type HIV-2 susceptible de provoquer le SIDA, et ses constituants antigéniques et nucléiques
EP0787191B1 (fr) Sequences nucleotidiques d'antigenes retroviraux vih-1 groupe (ou sous-groupe) o
FR2606030A1 (fr) Retrovirus recombinant defectif, son procede de fabrication et ses applications, notamment pour l'etude de l'interaction des retrovirus sauvages avec des lignees cellulaires infectables par celui-ci
CA2370563C (fr) Vaccin anti-vih-1 comprenant tout ou partie de la proteine tat de vih-1
FR2621128A1 (fr) Trousse et methode de dosage immunometrique applicables a des cellules entieres
EP0946731B1 (fr) Souches de vih-1 non-m non-o, fragments et applications
EP0577458B1 (fr) Séquences nucléotidiques et peptidiques issues de la souche Wo du VIF et applications desdites séquences au diagnostic et à la prévention de l'immunodéficience féline
EP0594822B1 (fr) Ensemble de moyens pour le dosage quantitatif de rétrovirus, procédé pour sa préparation et kit de diagnostic comprenant ledit ensemble
WO2001044438A2 (fr) Bacterie rickettsia pulicis methode de diagnostic serologique
EP0752102A1 (fr) Conjugue immunoenzymatique, son procede de preparation et ses applications
WO1996023226A9 (fr) Conjugue immunoenzymatique, son procede de preparation et ses applications
EP0769058A1 (fr) Fragments d'acide nucleique et fragments peptidiques correspondants issus du genome du virus de l'arthrite et de l'encephalite caprine (vaec) et leurs applications
Jones et al. Oxidant production by human B lymphocytes: detection of activity and identification of components involved
EP0373070A1 (fr) Procédé de préparation d'une librairie de déterminants antigéniques peptidiques, nouveaux peptides constitués par ou comportant les déterminants antigéniques obtenus et application des peptides, notamment au diagnostic
EP2705368B1 (fr) Utilisation de ef-1 et de ses homologues, pour detecter une proteine retrovirale p24 ou un homologue de celle-ci
CA2491407A1 (fr) Methode de diagnostic serologique
FR2726006A1 (fr) Sequences nucleotidiques codant des antigenes d'un retrovirus du type vih-1 groupe o
FR2788057A1 (fr) Reactif de detection et de suivi des infections virales a vih et ses applications
FR2837284A1 (fr) Methode de diagnostic serologique in vitro des endocardites infectieuses
HK58597A (en) HIV-3 retrovirus and its use
FR2692270A1 (fr) Peptides immunogènes et/ou neutralisants de vif de souche WO et leurs applications au diagnostic et à la prévention de l'immunodéficience féline.